Saliba, Faouzi

Publishing since 1986 (Dinosaur)

Has published 56 publications in 25 years

Number of publications published per year by Saliba, Faouzi. (Source : PubMed)

Distribution of publications types for Saliba, Faouzi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Levesque E, Hoti E, Azoulay D, Adam R, Samuel D, Castaing D, Saliba F. Non-invasive ICG-clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation.  Clin Transplant  2010  
•  Saliba F, Ichaï P, Azoulay D, Habbouchi H, Antonini T, Sebagh M, Adam R, Castaing D, Samuel D. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns.  Ther Apher Dial  2010;14;1  
•  Lebrec D, Thabut D, Oberti F, Perarnau JM, Condat B, Barraud H, Saliba F, Carbonell N, Renard P, Ramond MJ, Moreau R, Poynard T. Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis.  Gastroenterology  2010  
•  De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.  Liver Transpl.  2009;15;10  
•  Levesque E, Saliba F, Benhamida S, Ichaï P, Azoulay D, Adam R, Castaing D, Samuel D. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.  Liver Transpl.  2009;15;10  
•  Ichaï P, Saliba F. [Fulminant and subfulminant hepatitis: causes and treatment]  Presse Med  2009;38;9  
•  Karie-Guigues S, Janus N, Saliba F, Dumortier J, Duvoux C, Calmus Y, Lorho R, Deray G, Launay-Vacher V, Pageaux GP. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.  Liver Transpl.  2009;15;9  
•  Nashan B, Saliba F, Durand F, Barcéna R, Herrero JI, Mentha G, Neuhaus P, Bowles M, Patch D, Bernardos A, Klempnauer J, Bouw R, Ives J, Mamelok R, McKay D, Truman M, Marotta P. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.  Liver Transpl.  2009;15;2  
•  Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.  Liver Transpl.  2008;14;12  
•  Botterel F, Farrugia C, Ichai P, Costa JM, Saliba F, Bretagne S. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.  Transplant infectious disease : an official journal of the Transplantation Society  2008;10;5  

[ See timeline ] [ See all publications ]